4.5 Article

High-dose intravenous vitamin C attenuates hyperinflammation in severe coronavirus disease 2019

Related references

Note: Only part of the references are listed.
Article Critical Care Medicine

Pilot trial of high-dose vitamin C in critically ill COVID-19 patients

Jing Zhang et al.

Summary: In this trial, high-dose vitamin C infusion did not improve IMVFD28 for patients with severe COVID-19, but may have a potential benefit in oxygenation.

ANNALS OF INTENSIVE CARE (2021)

Article Medicine, General & Internal

Hyper-Inflammatory Response Involves in Cardiac Injury among Patients with Coronavirus Disease 2019

Guozhi Xia et al.

AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2021)

Article Medicine, General & Internal

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang et al.

LANCET (2020)

Editorial Material Multidisciplinary Sciences

Cytokine release syndrome in severe COVID-19

John B. Moore et al.

SCIENCE (2020)

Letter Medicine, General & Internal

COVID-19: consider cytokine storm syndromes and immunosuppression

Puja Mehta et al.

LANCET (2020)

Review Pharmacology & Pharmacy

Molecular immune pathogenesis and diagnosis of COVID-19

Xiaowei Li et al.

JOURNAL OF PHARMACEUTICAL ANALYSIS (2020)

Editorial Material Allergy

Weathering the Cytokine Storm in Susceptible Patients with Severe SARS-CoV-2 Infection

Brian Lipworth et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2020)

Review Medicine, General & Internal

Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19) A Review

W. Joost Wiersinga et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Microbiology

Immunomodulatory and Antimicrobial Effects of Vitamin C

Soraya Mousavi et al.

EUROPEAN JOURNAL OF MICROBIOLOGY AND IMMUNOLOGY (2019)

Review Immunology

Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology

Rudragouda Channappanavar et al.

SEMINARS IN IMMUNOPATHOLOGY (2017)

Article Medicine, Research & Experimental

Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis

Alpha A. Fowler et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2014)